QA: Hepion Pharmaceuticals Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001583771_2023_Hepion_Pharmaceuticals_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001583771, Hepion Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 56,496,073
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 81,620
3 remainder_Assets 3,666,759
4 LiabilitiesCurrent 7,885,722
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,502,793
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,348,465
9 ResearchAndDevelopmentExpense 33,269,337
10 remainder_Expenses -1,002,761
11 remainder_Revenues 0
12 remainder_NetIncome 414,992
13 remainder_ComprehensiveNetIncome -90,168
  yvar yval
0 Assets 60,244,452
1 Liabilities 10,388,515
2 Expenses 42,615,041
3 Revenues 0
4 StockholdersEquity 49,855,937
5 NetIncome -42,200,049
6 ComprehensiveNetIncome -42,245,133
7 BaseVar 56,876,584
8 EconomicCapitalRatio 1.23

Edgar->Model Mapping

Feature Distribution

Change over Time